Aurelius acquires McKesson UK in corporate carve-out

Pan-European private equity group Aurelius has acquired integrated healthcare provider and LloydsPharmacy parent company McKesson UK for an enterprise value of £477m, representing its biggest transaction to date. A corporate carve-out from Texas-based healthcare company McKesson Corporation, the deal will be completed by Aurelius’ newly launched co-investment structure with Aurelius European Opportunities Fund IV controlling…

You must be a HM Subscriber to view this content.

Subscribe Now »